Articles related to HIV

Recent CDC findings have confirmed the first known cases of HIV transmission through nonsterile microneedling procedures at an unlicensed spa, highlighting significant lapses in infection control practices.

Early adjunctive corticosteroids in PJP management can be lifesaving for HIV-positive patients with hypoxemia, but their efficacy in HIV-negative patients warrants further investigation.

The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.

MySTIRisk’s AI-driven analysis offers a nuanced approach to identifying patients at heightened risk for STIs, providing a crucial tool in optimizing healthcare strategies and interventions in sexual health clinics.

Pharmacists are emerging as key players in expanding PrEP access, offering a unique opportunity to close the gap in HIV prevention. Learn how this shift could help us meet national HIV prevention goals.

Single-tablet regimen (STR) coverage under qualified health plans (QHPs) varies widely across the US. Although bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) coverage has grown over time, many QHPs in priority jurisdictions for the Ending the HIV Epidemic (EHE) have coinsurance requirements. Delay in QHP coverage and benefit design may hinder access to new antiretroviral treatment (ART) regimens.